Share on Facebook
Share on Twitter
Share on LinkedIn

Johnson & Johnson’s ($JNJ) Janssen unit is recalling 13,500 bottles of its top-selling anticoagulant Xarelto because of microbial contamination discovered in a sample.

According to a recall notice in the latest FDA Enforcement Report, the drugmaker said that it confirmed that a sales sample of the drug was contaminated after a customer complaint, and so initiated a nationwide, voluntary recall. The company reported that the product came from a plant in Gurabo, Puerto Rico. The plant was among four on the island that J&J slated two years ago for $225 million in upgrades.

Click here to read more.